Wikidata

(Q45113635)

English

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

scientific article published in November 2004

In more languages

Statements

title
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15492801
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15492801%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45113635&oldid=1090663725"